Stocks · News reference

Jones Trading Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $32

Aug 26, 2026, 3:15 PMBenzinga Newsdesk

Jones Trading analyst Justin Walsh initiates coverage on Seaport Therapeutics (NASDAQ:SPTX) with a Buy rating and announces Price Target of $32.

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Aug 26, 2026, 3:15 PM
Checked: Aug 26, 2026, 3:15 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 26, 2026, 5:36 PMBenzinga Newsdesk
Seaport Therapeutics shares are trading higher after Jones Trading initiated coverage on the stock with a Buy rating and announced a $32 price target.
Read original at benzinga
SPTX
BenzingaAug 20, 2026, 10:07 AMBenzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Seaport Therapeutics, Maintains $50 Price Target
Read original at benzinga
SPTX
BenzingaAug 3, 2026, 11:05 AMBenzinga Newsdesk
Seaport Therapeutics Q2 EPS $(1.78) Misses $(0.65) Estimate
Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of $(0.65) by 173.85 percent. This is a 72.19 percent increase over losses of $(6.40) per
Read original at benzinga
SPTX